Keyphrases
Structure Function
100%
Connexin
100%
Glycinamide
50%
4-aminobenzoic Acid
41%
Pore Blocker
41%
Connexin Channels
41%
Beta-blockers
25%
Glycoconjugates
16%
Defect Causes
8%
Relative Width
8%
Modified Cyclodextrins
8%
Serious Pathology
8%
Second Class
8%
Size Dependence
8%
Intercellular Communication
8%
Cataract
8%
Carbohydrates
8%
Cyclodextrin
8%
Skin Diseases
8%
Reconstitution
8%
High Affinity
8%
Second Messenger
8%
First-in-class
8%
Neuropathology
8%
Cx32
8%
Neuropathy
8%
Demyelination
8%
Site of Action
8%
Gap Junction Channel
8%
Molecular Permeability
8%
Molecular Mechanism
8%
Deafness
8%
Connexin 26
8%
Sensorineural Deafness
8%
X-linked Charcot-Marie-Tooth Disease
8%
Biophysical Studies
8%
Connexin Proteins
8%
Cellular Studies
8%
Pharmacology, Toxicology and Pharmaceutical Science
Gap Junction Protein
100%
Glycinamide
33%
Aminobenzoic Acid
27%
Cyclodextrin
11%
Glycoconjugate
11%
Perception Deafness
5%
Hearing Impairment
5%
Skin Disease
5%
Neuropathy
5%
Demyelination
5%
Cataract
5%
Hereditary Motor Sensory Neuropathy
5%
Diseases
5%
Neuroscience
Gap Junction Protein
100%
Glycinamide
33%
Aminobenzoic Acid
27%
Cyclodextrin
11%
Glycoconjugate
11%
Cell Communication
5%
Cataract
5%
Charcot-Marie-Tooth Disease
5%
Gap Junction
5%
Second Messenger System
5%
Neuropathy
5%